Navigation Links
Research Presented at ISHLT Shows Promise of Addressing Critical Organ Shortage and Better Organ Preservation
Date:4/10/2008

BOSTON, April 10 /PRNewswire/ -- Data from experimental work on the use of organs from cardiac arrested donors will be presented this week at the International Society for Heart and Lung Transplantation's 28th Annual Meeting and Scientific Sessions. Utilizing donors after cardiac death (DCD), also known as non-heart-beating donors (NHBDs) has the potential to overcome a critical shortage of suitable donor organs for lung, and possibly heart, transplantation.

In addition, strategies for organ preservation during transport from donor to recipient will be a primary topic of discussion at the ISHLT meeting running through Saturday at the Boston Marriott Copley Place and Hynes Convention Center.

"There is a worldwide shortage of quality donor organs for transplantation. This year, we are going to hear about clinical updates on non-heart-beating lung donors, and also exciting new experimental work on the possible use of hearts from cardiac-arrested donors," said Steven Tsui, M.D., F.R.C.S., Director of Transplantation and Surgeon, Papworth Hospital, U.K. "In addition, there has been a lot of interest in techniques aiming to maintain, and possibly improve, donor organ function once they have been removed from the donor."

NON-HEART-BEATING DONORS

Organ transplantation is currently limited by a shortage of suitable donors, which results in longer waiting times for patients and a substantial risk of dying before transplantation.

Promising research results suggest the potential to immediately increase the number of lungs available for transplantation. Although thousands of patients are on lung transplant waiting lists around the world, only a small percentage actually receive transplants. And likewise, a small proportion of individuals identified as organ donors actually have suitable lungs for transplantation.

During the ISHLT mini-oral session I: The Non-Heart Beating Donor for Heart Transplantation, Ayyaz Ali, F.R.C.S., Trans
'/>"/>

SOURCE International Society for Heart and Lung Transplantation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. RSV Researcher Makes Gains in Finding Treatments
2. New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting
3. Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research
4. SpineMark Partners With Regional Spine Leaders to Launch Its First Multisite Spine Research Organizations in Los Angeles, Denver
5. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
6. Navigenics(TM) Genome Analysis Used In Research Trial on the Impact of Providing Genetic Risk Assessments
7. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
8. ACORNs Oncology-focused Contract Research Organization Exceeds Projections
9. Low Acid Coffee Backed By Scientific Research
10. Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimers Disease
11. Stem Cell Research Provides Medical Breakthrough to Repair Heart Cell Damage Created by a Heart Attack

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...nn., Dec. 3 Cumberland ...oday that data from a recent clinical trial for Ca...us treatment for pain and fever, will be presented...rmacists (ASHP) Midyear Clinical Meeting in Las Ve... be displayed in a poster presentation on Monday, ...
(Date:12/3/2009)... 3 Alzheimer,s disease (AD) is one...receive. This irreversible, progressive brain dise... eventually even the ability to carry out the simp...g older people, AD affects as many as 2.4 million ...l Institute on Aging. ,, (Logo: http://www.n...
(Date:12/3/2009)... Calif., Dec. 3 Each yea...the United States (U.S.) and Europe participate in...atory experience under renowned faculty members at... Scholars - past, present and future - will have e...nity at www.amgenscholars.com . ,, "The new W...
Breaking Medicine Technology:New Caldolor(R) (ibuprofen) Injection Data to Be Presented at 44th American Society of Health-System Pharmacists Meeting 2New Caldolor(R) (ibuprofen) Injection Data to Be Presented at 44th American Society of Health-System Pharmacists Meeting 3Alzheimer's Research May Lead to Preventing the Debilitating Disease 2Alzheimer's Research May Lead to Preventing the Debilitating Disease 3New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists 2New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists 3Hummer owners claim moral high ground to excuse overconsumption 10002 1Hummer owners claim moral high ground to excuse overconsumption 10002 2Veterans Healing Initiative Formed to Help Meet Burgeoning Addiction and Mental Health Issues of Returning U S Veterans 57835 1Veterans Healing Initiative Formed to Help Meet Burgeoning Addiction and Mental Health Issues of Returning U S Veterans 57835 2Binge Drinking May Encourage Infection 57831 1
...irst RNA Antagonist Medicine to Be Tested in Patie...en, 6th June 2007 - Santaris Pharma, the Danish,bi...996, the,Company,s new RNA Antagonist of Bcl-2, ha...hase I/II clinical study in Chronic,Lymphocytic Le...ted,this week at the 2007 Annual Meeting of the Am...
...ust,s lead molecule, FP0011, exhibited a different...tolerance in mid- to,late-stage patients, STRASBOU....A., a,clinical stage product company specializing...eases of the nervous system, today,announced that ...molecule glutamate release inhibitor, FP0011, are ...
Other Medicine Technology:Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 2Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 3Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 4Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 5Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 6Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 7Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 8Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 9Faust Pharmaceuticals' Phase IIa Results for Parkinson's Disease,Presented at International Congress of Parkinson's Disease and,Movement Disorders 2Faust Pharmaceuticals' Phase IIa Results for Parkinson's Disease,Presented at International Congress of Parkinson's Disease and,Movement Disorders 3Faust Pharmaceuticals' Phase IIa Results for Parkinson's Disease,Presented at International Congress of Parkinson's Disease and,Movement Disorders 4
(Date:12/3/2009)... Mario Badescu Skin Care,s cult favorite ... 55 products receiving a 2009 ELLE Beauty Award ,...-- Mario Badescu Skin Care,s Drying Lotion has lon...ndustry insiders, and skin care divas, but its sel...d marks a considerable leap into the mainstream li...
(Date:12/3/2009)... Economic downturn causes demand for affo...de in Connecticut cites a sharp increase in demand...economic crisis which has led to an increase in al...blems. , (PRWEB) December...tment Center sees a huge spike in demand for its s...
(Date:12/3/2009)...ings, doubts linger about whether they cause brain...y News) -- Whether cell phones cause brain cancer ...udy confirms previous evidence suggesting that the...ts of brain tumors in Scandinavia found no substan...e became widespread, according to the report in th...
(Date:12/3/2009)...A JOLLA, Calif., Dec. 3 ...Biological Studies unanimously voted to elect thr...lla. ,, Fred Dotzler is co-founder and Managi...f. De Novo is investing $650 million from three fu...y companies. Dotzler founded Medicus Venture Partn...
(Date:12/3/2009)... Recent CBO analysis understates key factors contr...Newswire-USNewswire/ -- A new actuarial analysis b...ical claims in the new individual market will be 5...ter implementation of healthcare reform under the ..., excluding the impact of medical inflation. This...
Breaking Medicine News(10 mins):Health News:Economic Crisis Causes Acute Demand for Affordable Drug Addiction Treatment 2Health News:No Increase in Brain Tumors Seen From Cell Phones 2Health News:No Increase in Brain Tumors Seen From Cell Phones 3Health News:Salk Institute Board of Trustees Elects Leaders in Venture Capital and Publishing to its Membership 2Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 2Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 3Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 4
...009 AMERIGROUP Corporation (NYSE: AGP ) today... Sachs Leveraged Finance Healthcare Conference on ... the Company,s presentation, which begins Wednesda...able for 30 days, and can be accessed at the same ...
...Quantum Group, Inc. (NYSE Amex: QGP ) ( www.Quan...Companies Inc. to enhance its investor relations o...n their long-history of success in broadening visi...el J. Guillama, Chief Executive Officer of The Qua...
...Newswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical...nd supplier of,modernized traditional Chinese medi...ced that the Board of Directors declared an annual...ers, the initial,dividend of $.025 will be paid to...
...g the risks of burns, skin cancer and premature ag...ation. But with the founding of her new company, I...ngbeds.com ), and this week,s launch of an economy...re a far cry from tanning beds popular a decade ag...
...looks to improve operating efficiencies with advan...mline Health Solutions, Inc. (Nasdaq: STRM ) ann... -affiliated surgery department will implement Str...ced Cloud Computing Center. The deployment of Str...
...rt entitled The Finnish Health,Care System: A Valu...ectives,on the development needs of health care in...model on value-based health care to analyze Finnis... analysing the,effectiveness of health care. One o...
Other Medicine News:Health News:The Quantum Group Announces Engagement of RedChip Companies for Investor Relations Programs 2Health News:The Quantum Group Announces Engagement of RedChip Companies for Investor Relations Programs 3Health News:Tianyin Pharmaceutical Co., Inc. Announces Cash Dividend to Common Stockholders 2Health News:Island Sun Tanning Beds Launches Economy-Buster Sale on Healthier, More Eco-friendly Home Tanning Beds 2Health News:Streamline Health to Deliver Hosted Document Workflow Solution to Leading West Coast University-Affiliated Surgery Department 2Health News:Streamline Health to Deliver Hosted Document Workflow Solution to Leading West Coast University-Affiliated Surgery Department 3Health News:Streamline Health to Deliver Hosted Document Workflow Solution to Leading West Coast University-Affiliated Surgery Department 4Health News:Finland Seeks Systemic Changes in Health Care 2
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
Medicine Products: